The development and adoption of alternatives to animal testing in biomedical and toxicological research represents one of the most impactful welfare advances in the scientific use of animals.
The development of alternatives to animal testing has profound welfare implications given the hundreds of millions of animals used in biomedical and toxicological research annually. Each validated and adopted alternative method represents real welfare improvement for animals that would otherwise have been used in often painful procedures. Progress has been uneven across fields: cosmetics testing on animals has been banned in the EU and several other jurisdictions, while pharmaceutical safety testing retains significant animal requirements that alternatives cannot yet fully replace. The regulatory acceptance of alternative methods is often the rate-limiting step, as validated alternatives must be formally accepted by regulatory agencies before they can substitute for required animal tests. Investing in validation and regulatory harmonization is as important as developing the alternatives themselves.